Delivery Order SPE2DB22D1017-SPE2DB25FYPKP
Award Date 8/28/25
Potential Completion Date 8/29/25
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Forteo 560 MCG/2.24 ML pen injections valued at $7,333.28. This is a firm fixed price delivery order with an ultimate completion date of September 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was not made under any small business set-aside program and was competitively awarded. Forteo is a prescription...
- The Defense Logistics Agency awarded a delivery order valued at $7,190.02 to AmerisourceBergen Drug Corp for the supply of Forteo 560 mcg/2.24 ml pen injections on July 24, 2025, with completion targeted for July 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Forteo is a pharmaceutical treatment commonly prescribed for osteoporosis management,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,758.08 to AmerisourceBergen Drug Corp for the supply of Forteo 560 mcg/2.24 mL pen injections. This firm fixed price delivery order was awarded competitively on July 23, 2025, with an ultimate completion date of July 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Forteo is a pharmaceutical product used in the treatment of osteoporosis and bone-related...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,087.66 to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections) under a firm fixed-price contract. This non-set-aside award, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a single delivery transaction for pharmaceutical supplies to support federal medical procurement needs. The product will be delivered to AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a $22,105.54 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injections). This contract represents a firm fixed price delivery order with an ultimate completion date of August 12, 2025, and is being performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was utilized for this competitive award. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $128,226.03 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injections). This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery is scheduled for completion by July 29, 2025, with performance occurring at...
- The Defense Logistics Agency awarded a delivery order valued at $1,833.32 to AmerisourceBergen Drug Corp for Forteo (560 mcg/2.24 ml pen injections) on September 7, 2025, with completion scheduled for September 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. Forteo is a prescription medication used to treat osteoporosis and increase bone mass in patients at risk...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $49,054.76 to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections) on August 20, 2025, with completion scheduled for August 21, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of performance is...
- The Defense Logistics Agency awarded a $17,249.94 delivery order to AmerisourceBergen Drug Corp for the supply of Forteo 560 mcg/2.24 ml pen injections with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $2,749.98 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Forteo (teriparatide) 560 mcg/2.24 mL pen injections. This firm fixed-price, non-set-aside contract is classified as a delivery order with an ultimate completion date of September 11, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Forteo is a pharmaceutical product used to treat osteoporosis and bone-related...